Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
K Aasvee, M Jauhiainen, E Kurvinen, R Jordania, J Sundvall & C Ehnholm. (1999) Lipoprotein(a), apolipoprotein A-I and B serum levels in young families from Tallinn, Estonia. Relationships with other cardiovascular risk factors and nationality. Scandinavian Journal of Clinical and Laboratory Investigation 59:3, pages 179-189.
Read now
Read now
S. Janciauskiene, O. Al Rayyes, C.-H. Floren & S. Eriksson. (1997) Low density lipoprotein catabolism is enhanced by the cleaved form of alpha-1-antitrypsin. Scandinavian Journal of Clinical and Laboratory Investigation 57:4, pages 325-335.
Read now
Read now
Florian Kronenberg, Armin Steinmetz, Gerhard M. Kostner & Hans Dieplinger. (1996) Lipoprotein(a) in Health and Disease. Critical Reviews in Clinical Laboratory Sciences 33:6, pages 495-543.
Read now
Read now
S. Wållberg-Jonsson, A. Uddhammar, G. Dahlén & S. Rantapää-Dahlqvist. (1995) Lipoprotein (a) in relation to acute phase reaction in patients with rheumatoid arthritis and polymyalgia rheumatica. Scandinavian Journal of Clinical and Laboratory Investigation 55:4, pages 309-315.
Read now
Read now
Articles from other publishers (55)
Thor Ueland, Ola Kleveland, Annika E. Michelsen, Rune Wiseth, Jan Kristian Damås, Kirsten B. Holven, Pål Aukrust, Lars Gullestad, Arne Yndestad & Bente Halvorsen. (2019) Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction. International Journal of Cardiology 274, pages 348-350.
Crossref
Crossref
Paul S. Jellinger, Yehuda Handelsman, Paul D. Rosenblit, Zachary T. Bloomgarden, Vivian A. Fonseca, Alan J. Garber, George Grunberger, Chris K. Guerin, David S.H. Bell, Jeffrey I. Mechanick, Rachel Pessah-Pollack, Kathleen Wyne, Donald Smith, Eliot A. Brinton, Sergio Fazio, Michael Davidson, Paul S. Jellinger, Yehuda Handelsman, David S.H. Bell, Zachary T. Bloomgarden, Eliot A. Brinton, Michael H. Davidson, Sergio Fazio, Vivian A. Fonseca, Alan J. Garber, George Grunberger, Chris K. Guerin, Jeffrey I. Mechanick, Rachel Pessah-Pollack, Paul D. Rosenblit, Donald A. Smith, Kathleen Wyne, Michael Bush, Farhad Zangeneh, Yehuda Handelsman, David S.H. Bell, Zachary T. Bloomgarden, Eliot A. Brinton, Sergio Fazio, Vivian A. Fonseca, Alan J. Garber, George Grunberger, Chris K. Guerin, Paul S. Jellinger, Paul D. Rosenblit, Donald A. Smith, Kathleen Wyne & Michael H. Davidson. (2017) American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease. Endocrine Practice 23, pages 1-87.
Crossref
Crossref
Barbara Kollerits, Christiane Drechsler, Vera Krane, Claudia Lamina, Winfried März, Hans Dieplinger, Eberhard Ritz, Christoph Wanner & Florian Kronenberg. (2016) Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study. Nephrology Dialysis Transplantation 31:11, pages 1901-1908.
Crossref
Crossref
Long WangJuan ChenYing ZengJie WeiJinjin JingGe LiLi SuXiaojun TangTangchun WuLi Zhou. (2016)
Functional Variant in the
SLC22A3-LPAL2-LPA
Gene Cluster Contributes to the Severity of Coronary Artery Disease
. Arteriosclerosis, Thrombosis, and Vascular Biology 36:9, pages 1989-1996.
Crossref
Crossref
Konstantin A. Krychtiuk, Stefan P. Kastl, Sebastian L. Hofbauer, Anna Wonnerth, Georg Goliasch, Maria Ozsvar-Kozma, Katharina M. Katsaros, Gerald Maurer, Kurt Huber, Elisabeth Dostal, Christoph J. Binder, Stefan Pfaffenberger, Stanislav Oravec, Johann Wojta & Walter S. Speidl. (2015) Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a). Journal of Clinical Lipidology 9:4, pages 533-541.
Crossref
Crossref
Florian Kronenberg. (2014) Lipoprotein(a) in various conditions: To keep a sense of proportions. Atherosclerosis 234:1, pages 249-251.
Crossref
Crossref
Anne Langsted, Pia R. Kamstrup & Børge G. Nordestgaard. (2014) Lipoprotein(a): Fasting and nonfasting levels, inflammation, and cardiovascular risk. Atherosclerosis 234:1, pages 95-101.
Crossref
Crossref
K. M. Kostner, W. Marz & G. M. Kostner. (2013) When should we measure lipoprotein (a)?. European Heart Journal 34:42, pages 3268-3276.
Crossref
Crossref
Paul S. Jellinger, Donald A. Smith, Adi E. Mehta, Om Ganda, Yehuda Handelsman, Helena W. Rodbard, Mark D. Shepherd & John A. Seibel. (2012) American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. Endocrine Practice 18, pages 1-78.
Crossref
Crossref
Erdembileg Anuurad, Byambaa Enkhmaa & Lars Berglund. (2010) Enigmatic Role of Lipoprotein(a) in Cardiovascular Disease. Clinical and Translational Science 3:6, pages 327-332.
Crossref
Crossref
Howard A. Liebman & Ilene C. Weitz. 2010. Rutherford's Vascular Surgery. Rutherford's Vascular Surgery
588
598
.
S. S. Habib & M. Aslam. (2004) Lipids and lipoprotein(a) concentrations in Pakistani patients with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 6:5, pages 338-343.
Crossref
Crossref
Consuelo Fernández-Miranda, Manuel Paz, José Luis Aranda, Víctor Núñez, Pilar Gómez, Pilar Díaz-Rubio, Joaquín Martínez & Agustín Gómez de la Cámara. (2003) Homocisteína y progresión de la aterosclerosis de la arteria carótida en pacientes con enfermedad coronaria. Medicina Clínica 121:15, pages 561-564.
Crossref
Crossref
Sophie Gonbert, Sophie Malinsky, Andrei C. Sposito, Hervé Laouenan, Chantal Doucet, M.John Chapman & Joëlle Thillet. (2002) Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk. Atherosclerosis 164:2, pages 305-311.
Crossref
Crossref
Laura Horváth, Albert Császár, András Falus, Hans Dieplinger, Anna Horváth, Éva Puskás, Gabriella Halm, Anikó Bányai, Katalin Pálóczi, Elöd László, László Kalabay, László Romics & George Füst. (2002) IL-6 AND LIPOPROTEIN (a) [LP(a)] CONCENTRATIONS ARE RELATED ONLY IN PATIENTS WITH HIGH APO(a) ISOFORMS IN MONOCLONAL GAMMOPATHY. Cytokine 18:6, pages 340-343.
Crossref
Crossref
F. Müjgan Aynaci, Fazil Orhan, Asim Orem, Sermet Yildirmis & Yusuf Gedik. (2016) Effect of Antiepileptic Drugs on Plasma Lipoprotein (a) and Other Lipid Levels in Childhood. Journal of Child Neurology 16:5, pages 367-369.
Crossref
Crossref
Rhobert W Evans, Ofer Shpilberg, B.Jessica Shaten, Shabnam Ali, M.Ilyas Kamboh & Lewis H Kuller. (2001) Prospective association of lipoprotein(a) concentrations and apo(a) size with coronary heart disease among men in the Multiple Risk Factor Intervention Trial. Journal of Clinical Epidemiology 54:1, pages 51-57.
Crossref
Crossref
JoAnne Micale Foody, John A Milberg, Gregory L Pearce & Dennis L Sprecher. (2000) Lipoprotein(a) associated with coronary artery disease in older women: age and gender analysis. Atherosclerosis 153:2, pages 445-451.
Crossref
Crossref
Vincent MooserMette M. BergerLuc TappyChristine CayeuxSantica M. MarcovinaRoger DarioliPascal NicodRené Chioléro. (2000) Major Reduction in Plasma Lp(a) Levels During Sepsis and Burns. Arteriosclerosis, Thrombosis, and Vascular Biology 20:4, pages 1137-1142.
Crossref
Crossref
Josef Zimmermann, Silke Herrlinger, Antje Pruy, Thomas Metzger & Christoph Wanner. (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney International 55:2, pages 648-658.
Crossref
Crossref
Paul N. Hopkins, Steven C. Hunt, Pamela J. Schreiner, John H. Eckfeldt, Ingrid B. Borecki, Curtis R. Ellison, Roger R. Williams & Kimberly D. Siegmund. (1998) Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease. Atherosclerosis 141:2, pages 333-345.
Crossref
Crossref
Randy RamharackDerek BarkalowMark A. Spahr. (1998) Dominant Negative Effect of TGF-β1 and TNF-α on Basal and IL-6–Induced Lipoprotein(a) and Apolipoprotein(a) mRNA Expression in Primary Monkey Hepatocyte Cultures. Arteriosclerosis, Thrombosis, and Vascular Biology 18:6, pages 984-990.
Crossref
Crossref
Giuseppe Lippi, Vania Braga, Silvano Adami & Giancesare Guidi. (1998) Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response. Clinica Chimica Acta 271:1, pages 79-87.
Crossref
Crossref
AKIN IŞĆN, RAMAZAN YIŞITOŞL̈, ALI ONAǦ, NUREDDIN VURGUN, ZEKI ARI, PELIN ERTAN & AHMET ZEKI ŞENGIL. (2007) Should children with infection be tested for lipid, lipoprotein and apolipoprotein?. Pediatrics International 40:1, pages 47-51.
Crossref
Crossref
Giuseppe Lippi & Giancesare Guidi. (1998) Standardization and Clinical Management of Lipoprotein(a) Measurements. cclm 36:1, pages 5-16.
Crossref
Crossref
Paul N. HopkinsLily L. WuSteven C. HuntBrent C. JamesG. Michael VincentRoger R. Williams. (1997) Lipoprotein(a) Interactions With Lipid and Nonlipid Risk Factors in Early Familial Coronary Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology 17:11, pages 2783-2792.
Crossref
Crossref
Won Seok Yang, Won Ki Min, Jung Sik Park & Soon Bae Kim. (1997) Effect of increasing serum albumin on serum lipoprotein(a) concentration in patients receiving CAPD. American Journal of Kidney Diseases 30:4, pages 507-513.
Crossref
Crossref
Catherine H. TuckStephen HolleranLars Berglund. (1997) Hormonal Regulation of Lipoprotein(a) Levels: Effects of Estrogen Replacement Therapy on Lipoprotein(a) and Acute Phase Reactants in Postmenopausal Women. Arteriosclerosis, Thrombosis, and Vascular Biology 17:9, pages 1822-1829.
Crossref
Crossref
F. Javier NietoPaul SorlieGeorge W. ComstockKenneth WuErwin AdamJoseph L. MelnickMoyses Szklo. (1997) Cytomegalovirus Infection, Lipoprotein(a), and Hypercoagulability: An Atherogenic Link?. Arteriosclerosis, Thrombosis, and Vascular Biology 17:9, pages 1780-1785.
Crossref
Crossref
David Crook, Rosemary Howell, Mandeep Sidhu, D.Keith Edmonds & John C. Stevenson. (1997) Elevated serum lipoprotein(a) levels in young women with endometriosis. Metabolism 46:7, pages 735-739.
Crossref
Crossref
Yoko Yano, Kuniyasu Shimokawa, Yume Okada & Akio Noma. (2016) Immunolocalization of Lipoprotein(a) in Wounded Tissues. Journal of Histochemistry & Cytochemistry 45:4, pages 559-568.
Crossref
Crossref
LYLE HUBINGER, LAUREL TRAEGER MACKINNON, LEE BARBER, JANE MCCOSKER, ALF HOWARD & FRANK LEPRE. (1997) Acute effects of treadmill running on lipoprotein(a) levels in males and females. Medicine & Science in Sports & Exercise 29:4, pages 436-442.
Crossref
Crossref
Kristina Orth-Gome´rMurray A. MittlemanKarin Schenck-GustafssonSarah P. WamalaMargita ErikssonKaren BelkicRichard KirkeeideBertil SvaneLars Ryde´n. (1997) Lipoprotein(a) as a Determinant of Coronary Heart Disease in Young Women. Circulation 95:2, pages 329-334.
Crossref
Crossref
M. Paassilta, K. Kervinen, K.J. Peuhkurinen & Y.A. Kesäniemi. (1996) Thrombolysis with tissue plasminogen activator enhances serum lipoprotein(a) levels compared to streptokinase and conservative treatment in patients with acute myocardial infarction. Fibrinolysis 10:5-6, pages 263-268.
Crossref
Crossref
Susanne Aull, Wolfgang Lalouschek, Peter Schnider, Helmut Sinzinger, Frank Uhl & Karl Zeiler. (1996) Dynamic changes of plasma lipids and lipoproteins in patients after transient ischemic attack or minor stroke. The American Journal of Medicine 101:3, pages 291-298.
Crossref
Crossref
Fop van KootenJohannes van KrimpenDiederik W.J. DippelNicoline HoogerbruggePeter J. Koudstaal. (1996) Lipoprotein(a) in Patients With Acute Cerebral Ischemia. Stroke 27:7, pages 1231-1235.
Crossref
Crossref
Florian Kronenberg, Gerd Utermann & Hans Dieplinger. (1996) Lipoprotein(a) in renal disease. American Journal of Kidney Diseases 27:1, pages 1-25.
Crossref
Crossref
Paul M. Ridker. (1995) An epidemiologic reassessment of lipoprotein(a) and atherothrombotic risk. Trends in Cardiovascular Medicine 5:6, pages 225-229.
Crossref
Crossref
Adrian S. Dobs, Mukesh Prasad, Anne Goldberg, Marcella Guccione & Donald R. Hoover. (1995) Changes in serum lipoprotein(a) in hyperlipidemic subjects undergoing long-term treatment with lipid-lowering drugs. Cardiovascular Drugs and Therapy 9:5, pages 677-684.
Crossref
Crossref
A Orem, O Deger, O Memis, S Bahadir, E Ovali & G Cimsit. (1995) Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behcet's disease.. Annals of the Rheumatic Diseases 54:9, pages 726-729.
Crossref
Crossref
Daniel M. Levine & Bruce R. Gordon. (1995) Lipoprotein(a) levels in patients receiving renal replacement therapy: methodologic issues and clinical implications. American Journal of Kidney Diseases 26:1, pages 162-169.
Crossref
Crossref
Kelly A. Frazer, Goutham Narla, Jun Li Zhang & Edward M. Rubin. (1995) The apolipoprotein(a) gene is regulated by sex hormones and acute–phase inducers in YAC transgenic mice. Nature Genetics 9:4, pages 424-431.
Crossref
Crossref
Gabriëlle A E Ponjee, Eugene M E Janssen & Jan W J van Wersch. (2016) Long-Term Physical Exercise and Lipoprotein(a) Levels in a Previously Sedentary Male and Female Population. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 32:2, pages 181-185.
Crossref
Crossref
Asun Örem, Orhan Değer, Gülseren Çimşit, S. Caner Karahan, Nurettin Akyol & Sermet Yldirimiş. (1995) Plasma Lipoprotein(a) and Its Relationship with Disease Activity in Patients with Behçet’s Disease. Clinical Chemistry and Laboratory Medicine 33:8.
Crossref
Crossref
Yechiel Friedlander & Eran Leitersdorf. (2005) Segregation analysis of plasma lipoprotein(a) levels in pedigrees with molecularly defined familial hypercholesterolemia. Genetic Epidemiology 12:2, pages 129-143.
Crossref
Crossref
Arne K. Andreassen, Kåre Berg & Harald Torsvik. (2008) Changes in Lp(a) lipoprotein and other plasma proteins during acute myocardial infarction. Clinical Genetics 46:6, pages 410-416.
Crossref
Crossref
Paul M. Ridker & Charles H. Hennekens. (1994) Lipoprotein(a) and risks of cardiovascular disease. Annals of Epidemiology 4:5, pages 360-362.
Crossref
Crossref
Gösta H. Dahlén. (1994) Lp(a) lipoprotein in cardiovascular disease. Atherosclerosis 108:2, pages 111-126.
Crossref
Crossref
CD Byrne & SH Wild. (1994) LIPOPROTEIN(α) IN HEALTH AND DISEASE. International Journal of Clinical Practice 48:4, pages 206-211.
Crossref
Crossref
A. Noma, A. Abe, S. Maeda, M. Seishima, K. Makino, Y. Yano & K. Shimokawa. (1994) Lp(a): an acute-phase reactant?. Chemistry and Physics of Lipids 67-68, pages 411-417.
Crossref
Crossref
Guillermo C. Cardoso, Carlos Posadas, Omar O. Orvanaños, Celia Peniche, Jose Zamora, Rocio Aguilar, Jose A. Holguin, Allen S. Raynaud, Joel D. Morrisett & Juan GuevaraJr.Jr.. (1994) Long distance runners and body-builders exhibit elevated plasma levels of lipoprotein(a). Chemistry and Physics of Lipids 67-68, pages 207-221.
Crossref
Crossref
Thomas B. Ledue, Louis M. Neveux, Glenn E. Palomaki, Robert F. Ritchie & Wendy Y. Craig. (1993) The relationship between serum levels of lipoprotein(a) and proteins associated with the acute phase response. Clinica Chimica Acta 223:1-2, pages 73-82.
Crossref
Crossref
Robert S. Rosenson. (1993) Myocardial injury: The acute phase response and lipoprotein metabolism. Journal of the American College of Cardiology 22:3, pages 933-940.
Crossref
Crossref
G.H. Dahlén, L. Slunga, G. Holmlund, A. Langö & B. Lindblom. (2007) Lp(a) LIPOPROTEIN AND HLA‐DR GENOTYPE IN EARLY CORONARY ARTERY DISEASE. International Journal of Immunogenetics 20:2, pages 95-102.
Crossref
Crossref
L. Slunga, O. Johnson & G. H. Dahlén. (1992) Changes in Lp(a) lipoprotein levels during the treatment of hypercholesterolaemia with simvastatin. European Journal of Clinical Pharmacology 43:4, pages 369-373.
Crossref
Crossref